Latest filing published 25 Feb 2026 for U S Physical Therapy INC /nv.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +115.3%Entry US$8.42 · Close at T+365 US$18.13
- -4.3%Entry US$14.50 · Close at T+365 US$13.87
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Christopher J. Reading: trading record in brief
Christopher J. Reading is a declared insider of U S Physical Therapy INC /nv (chief executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 9 May 2006 to 23 February 2026, the count stands at 71 filings.
The open-market side counts 7 purchases for €37k alongside 37 sales for €17.8M. On balance, insiders were net sellers of €17.8M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 20 share grants and 4 option exercises.
In size, the median ticket on the buying side is €4,354. After 7 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +62.8%. Past outcomes like these are no guarantee of what comes next.
On 25 February 2026 came the latest disclosure, a share grant in U S Physical Therapy INC /nv. The clock since the last published purchase (10 March 2009) now reads 6,452 days. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christopher J. Reading
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares0Common StockSEC:0001193125-26-072717:0
- 2,000 shares@ US$83.535.1% of flowCommon StockSEC:0000950170-25-113254:0
- 20,250 shares0Common StockSEC:0000950170-25-028168:0
- 2,900 shares@ US$100.269.6% of flowCommon StockSEC:0000950170-24-067492:0
- 1,000 shares@ US$100.130.8% of flowCommon StockSEC:0000950170-24-066088:1
- 1,100 shares@ US$102.133.7% of flowCommon StockSEC:0000950170-24-066088:0
- 16,200 shares0Common StockSEC:0000950170-24-022521:0
- 10,000 shares0Common StockSEC:0001209191-23-012213:0
- 5,000 shares@ US$90.0015.3% of flowCommon StockSEC:0001209191-22-060139:0
- 10,000 shares@ US$90.0130.6% of flowCommon stockSEC:0001209191-22-059618:0
- 20,000 shares0Common StockSEC:0001209191-22-018693:0
- 12,000 shares@ US$93.8935.6% of flowCommon StockSEC:0001209191-21-070494:0
- 11,200 shares0Common StockSEC:0001209191-21-013683:0
- 6,000 shares@ US$106.6715.9% of flowCommon StockSEC:0001209191-20-061820:0
- 14,380 shares0Common StockSEC:0001209191-20-016492:0
- 601 shares@ US$135.390.8% of flowCommon StockSEC:0001209191-19-046692:0
- 1,500 shares@ US$135.072.0% of flowCommon StockSEC:0001209191-19-046692:1
- 4,899 shares@ US$135.126.5% of flowCommon StockSEC:0001209191-19-046692:2
- 10,000 shares@ US$118.2211.4% of flowCommon StockSEC:0001209191-19-032020:0
- 9,860 shares@ US$120.5211.5% of flowCommon StockSEC:0001209191-19-032020:1
- 20,451 shares0Common StockSEC:0001209191-19-016719:0
- 8,768 shares@ US$115.578.2% of flowCommon StockSEC:0001209191-18-046737:0
- 781 shares@ US$116.580.7% of flowCommon StockSEC:0001209191-18-045799:0
- 451 shares@ US$115.780.4% of flowCommon StockSEC:0001209191-18-045799:1
- 13,639 shares@ US$92.018.7% of flowCommon StockSEC:0001209191-18-029508:0
25 of 71 declarations
